DK3364975T3 - Kombination af trazodon og gabapentin til behandling af smerter - Google Patents
Kombination af trazodon og gabapentin til behandling af smerter Download PDFInfo
- Publication number
- DK3364975T3 DK3364975T3 DK16781816.0T DK16781816T DK3364975T3 DK 3364975 T3 DK3364975 T3 DK 3364975T3 DK 16781816 T DK16781816 T DK 16781816T DK 3364975 T3 DK3364975 T3 DK 3364975T3
- Authority
- DK
- Denmark
- Prior art keywords
- trazodone
- gabapentin
- pain
- treatment
- combination
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title 2
- 229960002870 gabapentin Drugs 0.000 title 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 title 1
- 229960003991 trazodone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191024 | 2015-10-22 | ||
| PCT/EP2016/074835 WO2017067870A1 (en) | 2015-10-22 | 2016-10-17 | Combination of trazodone and gabapentin for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3364975T3 true DK3364975T3 (da) | 2021-06-21 |
Family
ID=54345445
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21158825.6T DK3881845T3 (da) | 2015-10-22 | 2016-10-17 | Kombination af trazodon og gabapentin til smertebehandling |
| DK16781816.0T DK3364975T3 (da) | 2015-10-22 | 2016-10-17 | Kombination af trazodon og gabapentin til behandling af smerter |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21158825.6T DK3881845T3 (da) | 2015-10-22 | 2016-10-17 | Kombination af trazodon og gabapentin til smertebehandling |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US10786498B2 (da) |
| EP (2) | EP3881845B1 (da) |
| JP (1) | JP6924184B2 (da) |
| KR (1) | KR102691296B1 (da) |
| CN (1) | CN108174599B (da) |
| AR (1) | AR106415A1 (da) |
| AU (1) | AU2016341063B2 (da) |
| BR (1) | BR112018007374B1 (da) |
| CA (1) | CA2999389C (da) |
| CY (1) | CY1124229T1 (da) |
| DK (2) | DK3881845T3 (da) |
| EA (2) | EA202190626A3 (da) |
| ES (2) | ES2879392T3 (da) |
| FI (1) | FI3881845T3 (da) |
| GE (2) | GEP20207145B (da) |
| HR (2) | HRP20250248T1 (da) |
| HU (2) | HUE071186T2 (da) |
| IL (1) | IL258316B (da) |
| LT (2) | LT3881845T (da) |
| MD (2) | MD3881845T2 (da) |
| MX (1) | MX380433B (da) |
| PL (2) | PL3881845T3 (da) |
| PT (2) | PT3881845T (da) |
| RS (2) | RS66607B1 (da) |
| SI (2) | SI3881845T1 (da) |
| SM (2) | SMT202500150T1 (da) |
| UA (1) | UA122245C2 (da) |
| WO (1) | WO2017067870A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201900006602A1 (it) * | 2019-05-07 | 2020-11-07 | Acraf | Composizione farmaceutica per il trattamento del dolore neuropatico |
| EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004271796A1 (en) * | 2003-09-12 | 2005-03-24 | Warner-Lambert Company Llc | Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders |
| NZ545494A (en) * | 2003-09-12 | 2009-10-30 | Pfizer | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
| US20080096872A1 (en) * | 2004-12-22 | 2008-04-24 | Friedman Robert S | Composition for Treatment of Pain Specification |
| US20120083508A1 (en) * | 2006-12-22 | 2012-04-05 | Allergan, Inc. | Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| EP2179015B1 (en) * | 2007-07-18 | 2013-06-05 | Dow Global Technologies LLC | Water-glycol hydraulic fluid compositions |
| WO2009021058A2 (en) * | 2007-08-06 | 2009-02-12 | Trinity Labortories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| US20100004485A1 (en) * | 2008-07-02 | 2010-01-07 | Teva Pharmaceutical Industries Ltd. | Gabapentin enacarbil salts and processes for their preparation |
| JP5893135B2 (ja) | 2011-06-28 | 2016-03-23 | ビボゾーン インコーポレイテッド | 多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途 |
-
2016
- 2016-10-17 BR BR112018007374-1A patent/BR112018007374B1/pt active IP Right Grant
- 2016-10-17 ES ES16781816T patent/ES2879392T3/es active Active
- 2016-10-17 LT LTEP21158825.6T patent/LT3881845T/lt unknown
- 2016-10-17 HU HUE21158825A patent/HUE071186T2/hu unknown
- 2016-10-17 CN CN201680059627.1A patent/CN108174599B/zh active Active
- 2016-10-17 MX MX2018004532A patent/MX380433B/es unknown
- 2016-10-17 MD MDE20220430T patent/MD3881845T2/ro unknown
- 2016-10-17 PT PT211588256T patent/PT3881845T/pt unknown
- 2016-10-17 SM SM20250150T patent/SMT202500150T1/it unknown
- 2016-10-17 HU HUE16781816A patent/HUE054653T2/hu unknown
- 2016-10-17 PT PT167818160T patent/PT3364975T/pt unknown
- 2016-10-17 ES ES21158825T patent/ES3015662T3/es active Active
- 2016-10-17 EA EA202190626A patent/EA202190626A3/ru unknown
- 2016-10-17 EP EP21158825.6A patent/EP3881845B1/en active Active
- 2016-10-17 GE GEAP201614778A patent/GEP20207145B/en unknown
- 2016-10-17 EP EP16781816.0A patent/EP3364975B1/en active Active
- 2016-10-17 WO PCT/EP2016/074835 patent/WO2017067870A1/en not_active Ceased
- 2016-10-17 RS RS20250252A patent/RS66607B1/sr unknown
- 2016-10-17 SM SM20210352T patent/SMT202100352T1/it unknown
- 2016-10-17 IL IL258316A patent/IL258316B/en unknown
- 2016-10-17 UA UAA201804930A patent/UA122245C2/uk unknown
- 2016-10-17 MD MDE20180825T patent/MD3364975T2/ro unknown
- 2016-10-17 US US15/767,543 patent/US10786498B2/en active Active
- 2016-10-17 PL PL21158825.6T patent/PL3881845T3/pl unknown
- 2016-10-17 SI SI201631895T patent/SI3881845T1/sl unknown
- 2016-10-17 AU AU2016341063A patent/AU2016341063B2/en active Active
- 2016-10-17 EA EA201890911A patent/EA037838B1/ru unknown
- 2016-10-17 KR KR1020187013499A patent/KR102691296B1/ko active Active
- 2016-10-17 RS RS20210740A patent/RS61989B1/sr unknown
- 2016-10-17 JP JP2018519360A patent/JP6924184B2/ja active Active
- 2016-10-17 LT LTEP16781816.0T patent/LT3364975T/lt unknown
- 2016-10-17 DK DK21158825.6T patent/DK3881845T3/da active
- 2016-10-17 FI FIEP21158825.6T patent/FI3881845T3/fi active
- 2016-10-17 DK DK16781816.0T patent/DK3364975T3/da active
- 2016-10-17 PL PL16781816T patent/PL3364975T3/pl unknown
- 2016-10-17 GE GEAP202014778A patent/GEAP202014778A/en unknown
- 2016-10-17 HR HRP20250248TT patent/HRP20250248T1/hr unknown
- 2016-10-17 HR HRP20210832TT patent/HRP20210832T1/hr unknown
- 2016-10-17 SI SI201631218T patent/SI3364975T1/sl unknown
- 2016-10-17 CA CA2999389A patent/CA2999389C/en active Active
- 2016-10-20 AR ARP160103200A patent/AR106415A1/es unknown
-
2020
- 2020-04-15 US US16/849,545 patent/US11752147B2/en active Active
-
2021
- 2021-06-18 CY CY20211100546T patent/CY1124229T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269371A (en) | Treatment methods | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3277815T3 (da) | Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser | |
| DK3360508T3 (da) | Hjælpeanordning til dental behandling | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| DK3285803T3 (da) | Fremgangsmåder til behandling eller forebyggelse af migrænehovedpine | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3303339T3 (da) | Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
| DK2994157T3 (da) | Tafa4-forbindelser og anvendelser deraf til behandling af smerte | |
| HUE050944T2 (hu) | Kezelési eljárás tradipitant alkalmazásával | |
| DK3142664T3 (da) | Sammensætninger og fremgangsmåder til behandling og diagnosticering af øjensygdomme | |
| DK3191103T3 (da) | Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner | |
| DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
| IL254825A0 (en) | Methods of treatment with taselisib | |
| EP3493821A4 (en) | METHOD OF TREATING THE RESPIRATORY TRACT | |
| DK3122743T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme | |
| DK3169405T3 (da) | Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme |